
Join to View Full Profile
685 Stanley AvenueCincinnati, OH 45226
Phone+1 513-515-1836
Dr. Winkelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Winkelmann is retired hematology oncology specialist. He completed his medical education at the University of Minnesota Medical School in 1981, followed by an internal medicine residency at the University of Texas Southwestern Medical Center and a fellowship in hematology and medical oncology at Yale-New Haven Medical Center. Dr. Winkelmann has contributed to several publications, including research on subjects like paclitaxel-induced conditions and erythropoietin receptors, with varying citation counts.
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1981 - 1984
- University of Minnesota Medical SchoolClass of 1981
Certifications & Licensure
- KY State Medical License 1998 - 2022
- OH State Medical License 1993 - 2021
- MN State Medical License 1982 - 1994
- TX State Medical License 1982 - 1986
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 9 citationsPaclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis.Richard R. Winkelmann, James A. Yiannias, David J. DiCaudo, Shannon C. Trotter, Yolanda Farhey
International Journal of Dermatology. 2016-01-01 - 4 citationsThe Affordable Care Act: where are we now? An NCCN roundtable.Christian G. Downs, Liz Fowler, Michael Kolodziej, Lee H. Newcomer, Mohammed S. Ogaily
Journal of the National Comprehensive Cancer Network. 2014-05-01 - 96 citationsFox-2 Splicing Factor Binds to a Conserved Intron Motif to Promote Inclusion of Protein 4.1R Alternative Exon 16Julie L. Ponthier, Christina Schluepen, Weiguo Chen, Robert A. Lersch, Sherry L. Gee
The Journal of Biological Chemistry. 2006-05-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: